Form 8-K - Current report:
SEC Accession No. 0001193125-25-181840
Filing Date
2025-08-15
Accepted
2025-08-15 16:00:49
Documents
15
Period of Report
2025-08-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d41745d8k.htm   iXBRL 8-K 37934
2 EX-2.1 d41745dex21.htm EX-2.1 626522
3 EX-2.2 d41745dex22.htm EX-2.2 114225
  Complete submission text file 0001193125-25-181840.txt   1133090

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xoma-20250811.xsd EX-101.SCH 4580
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20250811_def.xml EX-101.DEF 14449
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20250811_lab.xml EX-101.LAB 24599
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20250811_pre.xml EX-101.PRE 15482
18 EXTRACTED XBRL INSTANCE DOCUMENT d41745d8k_htm.xml XML 7796
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 251224496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)